Hjem › Akut myelogen leukemi › Virginia › Arlington
Kliniske studier for Akut myelogen leukemi i Arlington, VA
8 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
RekruttererFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi unna
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Inova Fairfax Hospital, Falls Church · 4 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Inova Fairfax Hospital, Falls Church · 4 mi unna
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- Virginia Cancer Specialists, Manassas · 22 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft46 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Tripelnegativ brystkreft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.